Chun-teng Huang
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Targeting SET to counteract Lyn activation demonstrates anti-cancer potential in diffuse large B-cell lymphoma.
Journal: Clinical and experimental medicine
Published: March 31, 2025
MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 25, 2024
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.
Journal: Experimental cell research
Published: October 06, 2022
Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma.
Journal: Molecular medicine (Cambridge, Mass.)
Published: January 16, 2022
Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
Journal: EBioMedicine
Published: July 15, 2019
Aspirin and Risk of Dementia in Patients with Late-Onset Depression: A Population-Based Cohort Study.
Journal: BioMed research international
Published: February 23, 2019
SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment.
Journal: Journal of clinical medicine
Published: August 09, 2018
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Journal: EBioMedicine
Published: July 09, 2018
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
Journal: PloS one
Published: May 10, 2017
Last Updated: 09/26/2026